Related Experiment Video
Updated: Jun 13, 2026

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion
Published on: April 27, 2015
Blood purification in fulminant hepatic failure
High-flow dialysate continuous hemodiafiltration (HFCHDF) effectively treats fulminant hepatic failure (FHF) by improving consciousness and survival. This blood purification method also reduces ammonia levels and prevents side effects associated with plasma exchange.
Area of Science:
- Hepatology
- Nephrology
- Critical Care Medicine
Background:
- Fulminant hepatic failure (FHF) is a critical condition characterized by acute liver dysfunction, hepatic encephalopathy (HE), and coagulopathy.
- Blood purification (BP) techniques are explored for managing HE and coagulopathy in FHF.
- Existing BP methods may have limitations or side effects requiring optimization.
Purpose of the Study:
- To outline the objectives and methods of BP in FHF treatment.
- To evaluate the efficacy and outcomes of a specific BP method, high-flow dialysate continuous hemodiafiltration (HFCHDF), in FHF patients.
- To compare HFCHDF with conventional continuous hemodiafiltration (CHDF) and assess its role in preventing plasma exchange (PE) side effects.
Main Methods:
- Implementation of HFCHDF by connecting a conventional CHDF console to a personal dialysis console, achieving dialysate flow rates up to 500 ml/min.
- Incorporation of slow plasma exchange (SPE) as needed.
- Retrospective analysis of data from 90 FHF patients treated with BP since 1990, focusing on neurological status, survival rates, and blood ammonia levels.
Main Results:
- HFCHDF treatment led to restoration of consciousness in 70.2% of patients (33 out of 47).
- Survival rates in the HFCHDF group were significantly higher compared to the CHDF group.
- HFCHDF demonstrated a reduction in blood ammonia levels and effectively prevented side effects of PE, such as hypernatremia and decreased colloid osmotic pressure.
Conclusions:
- HFCHDF is a valuable therapeutic option for managing hepatic encephalopathy in FHF.
- HFCHDF contributes to improved survival rates in FHF patients.
- The combination of HFCHDF and SPE is suggested as a standardized treatment protocol for FHF.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

